These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16312558)

  • 21. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ofloxacin on human colonic microflora.
    Ortisi G; Scarpellini P; Cernuschi M; Nicastro G; Moro M; Privitera G
    J Chemother; 1989 Jul; 1(4 Suppl):613-5. PubMed ID: 16312556
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy (PSE).
    Esposito S; Barba D; Galante D; Gaeta GB; Laghezza O
    Drugs Exp Clin Res; 1987; 13(10):641-6. PubMed ID: 3428128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.
    Goldstein EJ; Citron DM; Warren YA; Tyrrell KL; Merriam CV; Fernandez HT
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2875-9. PubMed ID: 16870792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First point prevalence survey of nosocomial infections in the intensive care units of a tertiary care hospital in Albania.
    Faria S; Sodano L; Dauri M; Sabato AF; Gjata A; Kito I; Llazo E; Bilaj A; Mertiraj O; Schinaia N;
    J Hosp Infect; 2008 May; 69(1):95-7. PubMed ID: 18346815
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment with cedax in asymptomatic bacteriuria in the first trimester of pregnancy].
    Pŭnevska M
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():26-7. PubMed ID: 11785352
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic wound infection and antimicrobial use.
    Landis SJ
    Adv Skin Wound Care; 2008 Nov; 21(11):531-40; quiz 541-2. PubMed ID: 18981758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of in vitro activity of teicoplanin against gram-positive anaerobic bacteria.
    Anzivino D; Nani E; Gulletta E; Lembo M; Covelli B
    J Chemother; 1989 Jul; 1(4 Suppl):201-2. PubMed ID: 16312368
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection.
    Adeleye IA; Uwagboe UC
    West Indian Med J; 2003 Dec; 52(4):325-6. PubMed ID: 15040073
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.
    Sotto A; Bouziges N; Jourdan N; Richard JL; Lavigne JP
    Pathol Biol (Paris); 2007 Nov; 55(8-9):398-406. PubMed ID: 17905534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing incidence of bacterial, resistance to antibiotics by isolates from the urinary tract.
    Ozumba UC
    Niger J Clin Pract; 2005 Dec; 8(2):107-9. PubMed ID: 16477864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of predominant bacteria of burn infection and their resistance to antibiotics in recent years].
    Li M; Zhang GA; Liu Y
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):91-3. PubMed ID: 17649879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Temporal pattern of ++resistance to ciprofloxacin in urinary infections].
    Mengoli C; Tonin E; Bertiato G; Rossi L; Peracchi M; Scarin M
    G Ital Chemioter; 1991; 38(1-3):151-2. PubMed ID: 1365574
    [No Abstract]   [Full Text] [Related]  

  • 35. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.
    Krasemann C; Von Poppel H; Wegge M; Chysky V
    J Chemother; 1989 Jul; 1(4 Suppl):386-8. PubMed ID: 16312452
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures.
    Sharifian M; Karimi A; Tabatabaei SR; Anvaripour N
    Jpn J Infect Dis; 2006 Dec; 59(6):380-2. PubMed ID: 17186957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple, effective and affordable approach for the treatment of burns infections.
    Nagoba BS; Gandhi RC; Hartalkar AR; Wadher BJ; Selkar SP
    Burns; 2010 Dec; 36(8):1242-7. PubMed ID: 20554394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of microbial etiology and mortality in patients with brain abscess.
    Prasad KN; Mishra AM; Gupta D; Husain N; Husain M; Gupta RK
    J Infect; 2006 Oct; 53(4):221-7. PubMed ID: 16436297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.
    Boerema JB; Olthof BJ; van Saene HK
    Scand J Infect Dis Suppl; 1986; 48():27-31. PubMed ID: 3095916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.